Karimzadeh A, Heck M, Tauber R, Solaris E, et al. The Impact of PSMA PET-Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy. J Nucl Med 2023 Jun 8:jnumed.122.265346. doi: 10.2967/jnumed.122.265346.
PMID: 37290796